-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Pharmaceutical Network Industry Dynamics: The inflated price of drugs has always been a hot and difficult issue of concern to the masses, to a certain extent, increased the cost of medical treatment for the masses, increased the burden of medical treatment, the State organized the centralized procurement of drugs, and focused on solving the problem of inflated drug pricesDrugs are produced by pharmaceutical manufacturers certified by the State Drug Administration's drug production quality management practices, and have passed the quality and efficacy consistency evaluation, although the price is significantly reduced, but the effectiveness and safety of drugs are guaranteed, the quality of drugs is guaranteed
On March 3, Shanghai Pharmaceutical Centralized Tender procurement Management Office officially issued the Notice on the Implementation of the Second Batch of National Drug Central Procurement of Selected Drugs in Shanghai, opening the prelude to the implementation of the second batch of national quantity procurement of selected drugsIt is reported that Shanghai, Gansu, Hebei, Guizhou, Qinghai, Ningxia, Liaoning, Shaanxi, Shanxi, Jiangxi, Heilongjiang, Guangdong, Hainan and other provinces and cities have started the selection of drugs declaration, hanging the net and price adjustment related matters
For example, on March 30, Heilongjiang Provincial Health Insurance Bureau carried out the second batch of state-organized centralized drug procurement (Heilongjiang) non-selected drug price linkage work, by enterprise quotation, publicity, processing complaints, on April 14 produced results, a total of 216 standard drug prices, an average reduction of 26.6%, the price linkage results on April 20 with the results of the election in Heilongjiang Province
As a result, some commonly used drugs in Heilongjiang significantly reduced prices, such as Yichang Fu Pharmaceuticalacetaminophen tablets (0.5g x 10 tablets) fell by 97%, Hangzhou Minsheng PharmaceuticalSal Hydrochloric acid left sitiliquin tablets (5mg x 14 tablets) fell by up to 9% 2%, as well as the antihypertensive drug Kandisatan tablets, the treatment of bronchial asthma drug Fdostam tablets, the prevention and treatment of tuberculosis drug isoniazid tablets, etchave dropped by more than 80%, drug centralized procurement once again brought significant benefits, after implementation will greatly reduce the financial burden of patients on medication
In addition to Heilongjiang Province on April 20, there are 216 drug price reduction, Shanxi Province from April 15, the province-wide implementation of 32 selected drugs price reduction resultsTo participate in the volume procurement of all medical institutions related drugs 50%-80% of the historical use as agreed procurement volume, to carry out volume purchase, to exchange prices, and simultaneously implement the medical insurance fund advance, medical insurance payment standards and procurement price coordination, strengthen clinical rational drug management, establish the evaluation mechanism for the use of selected drugs, strengthen drug quality supervision and other measures to promote the hospital priority use of reliable quality, reasonable price of selected drugs
In the context of the normalization of national band procurement, provincial platform band quantity procurement frequency, become the main force to force more drugs to achieve large price reductionWith the continuous deepening of band procurement, the use of market share for drug prices has formed a consensus, in the premise of grasping the quality of the red line, the future will be more and more varieties into the scope of band procurement, forcing enterprises to significantly reduce prices, squeeze drug prices moisture
The second batch of load procurement results are being implemented on the ground, and recently, there is news that the third round of belt quantity procurement will come, the relevant departments have been studying the list of drugs
The industry said that the next batch of band purchases will be at least three expansion: First, expand the scopeFrom the experience of the current pilot cities, the volume procurement is basically successful, followed by a direct and comprehensive pushFrom a national perspective, it is extended to all provinces, from a provincial point of view, to all municipalities, and from a municipal perspective, it may be extended to hospitals and retail pharmacies at different levelsAt present, some cities pilot retail pharmacies are involved in centralized band procurement
Second, expand the variety With the increase of over-rated varieties, the number of drug varieties included in the collection will be further increased, it is expected that the scale of the collection varieties will be larger than a batch
Third, expand basic work To institutionalize the research results and realize the integration and standardization of technical guidance on local bidding and procurement work - these work is conducive to improving the quality of collection work, because which varieties to collect, how to expand the scope, what policies, all need to go through the collection of information, only to solve the data problems, policy basis problems, in order to make the introduction of measures more targeted.